Loading...
NPI 1902865868 · South San Francisco, CA · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Monogram Biosciences, Inc is a clinical medical laboratory provider located in South San Francisco, California. This profile covers 7 Medicare and 10 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Monogram Biosciences, Inc |
| Address | 345 Oyster Point Blvd |
| City | South San Francisco |
| State | CA |
| ZIP | 94080 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | March 20, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $7.3M |
| Medicare | $406.8K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
7 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 87999 | Use 87999 to report microbiology procedures that do not have a specific code. | 110 | $1,920 | $219K |
| 87901 | The lab analyst performs the technical lab test to analyze the patient specimen, typically serum, for the reverse transcriptase and protease regions of the specific genotype of the virus causing the… | 340 | $250 | $84.9K |
| 87900 | The lab analyst measures a patient’s susceptibility or resistance to drugs aimed at a virus. The test predicts the behavior of the phenotype based on comparing patient data to regularly updated… | 340 | $130 | $43.1K |
| 87906 | The lab analyst performs the technical lab test to analyze the genotype of an HIV 1 virus by nucleic acid for regions other than the reverse transcriptase and protease regions, for example, the… | 330 | $130 | $41.5K |
| 87903 | The lab analyst performs the technical lab test to analyze the nucleic acids from a sample of tissue from an HIV 1 positive patient to determine drug resistance through culture analysis for up to the… | 20 | $450 | $7.7K |
| 87904 | The lab analyst performs the technical lab test to analyze the nucleic acids from a sample of tissue from an HIV 1–positive patient to determine drug resistance through culture analysis. Use this… | 240 | $20 | $5.8K |
| 87536 | A lab tests a patient’s specimen to measure the amount of HIV–1 present. This may be referred to as viral load. | 60 | $80 | $4.7K |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 7 CPT/HCPCS codes.
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
10 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 87901 | The lab analyst performs the technical lab test to analyze the patient specimen, typically serum, for the reverse transcriptase and protease regions of the specific genotype of the virus causing the… | 12,860 | $230 | $2.9M |
| 87906 | The lab analyst performs the technical lab test to analyze the genotype of an HIV 1 virus by nucleic acid for regions other than the reverse transcriptase and protease regions, for example, the… | 11,940 | $110 | $1.3M |
| 87900 | The lab analyst measures a patient’s susceptibility or resistance to drugs aimed at a virus. The test predicts the behavior of the phenotype based on comparing patient data to regularly updated… | 13,770 | $90 | $1.2M |
| 87999 | Use 87999 to report microbiology procedures that do not have a specific code. | 1,870 | $550 | $1M |
| 87536 | A lab tests a patient’s specimen to measure the amount of HIV–1 present. This may be referred to as viral load. | 4,570 | $70 | $324.6K |
| 87903 | The lab analyst performs the technical lab test to analyze the nucleic acids from a sample of tissue from an HIV 1 positive patient to determine drug resistance through culture analysis for up to the… | 700 | $390 | $270.7K |
| 87904 | The lab analyst performs the technical lab test to analyze the nucleic acids from a sample of tissue from an HIV 1–positive patient to determine drug resistance through culture analysis. Use this… | 560 | $140 | $79.4K |
| 87902 | The lab analyst performs the technical lab test to analyze the specific genotype by nucleic acid of a specimen containing hepatitis C virus. | 330 | $150 | $48.4K |
| 87522 | A lab tests a patient’s specimen to measure the amount of hepatitis C virus present. This may be referred to as viral load. | 1,270 | $20 | $30.4K |
| 87517 | The lab analyst performs a test to quantify infection with hepatitis B virus using nucleic acid probe technique. Hepatitis B virus, HBV, may cause acute or chronic liver disease. | 200 | $30 | $5.3K |
How this provider's Medicaid billing volume and revenue compare to other California providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. California median
10 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 87901 | The lab analyst performs the technical lab test to analyze the patient specimen, typically serum, for the reverse transcriptase and protease regions of the specific genotype of the virus causing the… | 1 | 10 | 2,550 | $150 | $569K |
| 87906 | The lab analyst performs the technical lab test to analyze the genotype of an HIV 1 virus by nucleic acid for regions other than the reverse transcriptase and protease regions, for example, the… | 1 | 10 | 1,980 | $90 | $297.2K |
| 87903 | The lab analyst performs the technical lab test to analyze the nucleic acids from a sample of tissue from an HIV 1 positive patient to determine drug resistance through culture analysis for up to the… | 1 | 10 | 700 | $390 | $270.8K |
| 87900 | The lab analyst measures a patient’s susceptibility or resistance to drugs aimed at a virus. The test predicts the behavior of the phenotype based on comparing patient data to regularly updated… | 1 | 10 | 2,530 | $60 | $234K |
| 87999 | Use 87999 to report microbiology procedures that do not have a specific code. | 1 | 10 | 60 | $260 | $164.4K |
| 87902 | The lab analyst performs the technical lab test to analyze the specific genotype by nucleic acid of a specimen containing hepatitis C virus. | 10 | 30 | 100 | $80 | $155K |
| 87536 | A lab tests a patient’s specimen to measure the amount of HIV–1 present. This may be referred to as viral load. | 11 | 130 | 270 | $30 | $103.6K |
| 87904 | The lab analyst performs the technical lab test to analyze the nucleic acids from a sample of tissue from an HIV 1–positive patient to determine drug resistance through culture analysis. Use this… | 1 | 10 | 560 | $140 | $79.3K |
| 87517 | The lab analyst performs a test to quantify infection with hepatitis B virus using nucleic acid probe technique. Hepatitis B virus, HBV, may cause acute or chronic liver disease. | 36 | 70 | 200 | $20 | $43.6K |
| 87522 | A lab tests a patient’s specimen to measure the amount of hepatitis C virus present. This may be referred to as viral load. | 41 | 350 | 170 | $20 | $20.1K |
Other providers in the same ZIP code as Monogram Biosciences, Inc, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Myriad Women's Health, Inc. | CA | Clinical Medical Laboratory | $0 | $146.7M |
| Veracyte, Inc. | CA | Clinical Medical Laboratory | $37.7M | $19.4M |
| Laguna Hills Pathology Lab LLC | CA | Clinical Medical Laboratory | $1M | $1.1M |
| Sebastian Sasu | CA | Anatomic Pathology & Clinical Pathology Physician | $180.2K | $0 |
| Jenny Kuo | CA | Anatomic Pathology & Clinical Pathology Physician | $76K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.